Jagsonpal Pharmaceuticals Share Price

NSE
JAGSNPHARM •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Jagsonpal Pharmaceuticals Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
30.34% Fall from 52W High
1.8
TTM PE Ratio
Above industry Median
29
Price to Book Ratio
High in industry
7.7
Dividend yield 1yr %
Below industry Median
0.9
TTM PEG Ratio
PEG TTM is less than 1
0.3

Jagsonpal Pharmaceuticals Ltd shareholding Pattern

Promoter
67.8%
Foreign Institutions
2.1%
Public
30.1%
Promoter
68%
Foreign Institutions
2.3%
Mutual Funds
0.1%
Domestic Institutions
0.1%
Public
29.6%
Promoter
68%
Foreign Institutions
1.1%
Domestic Institutions
0.8%
Public
30%
Promoter
68.1%
Foreign Institutions
0.7%
Domestic Institutions
0.9%
Public
30.3%
Promoter
68.5%
Foreign Institutions
0.5%
Domestic Institutions
0.9%
Public
30.2%
Promoter
68.7%
Foreign Institutions
0.4%
Domestic Institutions
0.8%
Public
30.1%

Jagsonpal Pharmaceuticals Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
4
Bearish Moving Averages
12
5Day EMA
238.10
10Day EMA
242.30
12Day EMA
242.70
20Day EMA
242.80
26Day EMA
242.80
50Day EMA
241.20
100Day EMA
227.40
200Day EMA
202.70
5Day SMA
239.90
10Day SMA
248.90
20Day SMA
242.20
30Day SMA
237.10
50Day SMA
247.90
100Day SMA
230.60
150Day SMA
205.40
200Day SMA
187.70
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
103550 Rs
379666 Rs
Week Rs
159876 Rs
604474 Rs
Month Rs
130642 Rs
617033 Rs
Resistance & Support
233.85
Pivot
Resistance
First Resistance
242.10
Second Resistance
255.70
Third Resistance
263.95
Support
First Support
220.25
Second support
212
Third Support
198.40
Relative Strength Index
45.73
Money Flow Index
64.71
MACD
-0.16
MACD Signal
1.28
Average True Range
25.07
Average Directional Index
17.47
Rate of Change (21)
2.49
Rate of Change (125)
52.33

Jagsonpal Pharmaceuticals Ltd Company background

Founded in: 1978
Managing director: Manish Gupta
Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana. The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs. Simultaneously, it has geared up to set up an ultra modern multipurpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd.The company has a strategic alliance with Fidia Spa, Italy and B Spofola, Czechoslovakia to manufacture sophisticated drugs in India. It has tied up with another Israelbased company, Makhteshim Chemical Works, for acquiring the marketing rights of an antioxidant product. In 1994, the company has also promoted Aresco Financial Services, a new financial company.The Companys RD activities have resulted in manufacturing process upgradation, improving packaging, and cost containment. Its RD activities are geared towards development of new product technologies which can be commercialised in future.It has tied up with Lycored Natural Products Industries (LNP) of Israel, to launch a completely natural Lycopene bioactive product, Lycored, in India and SouthEast Asia.In the fiscal 2001, the companys sales grew by 15% to Rs 136.52 crore and the profit at the net level was up 8% to Rs 10.15 crore. This was achieved against heavy odds, such as, sluggish market trends, lower growth rate of the industry and severe competition from drug majors. However the company has introduced various measures to counter the above factors so as to achieve continued growth and opportunity.The new manufacturing facility at Pantnagar, Uttarakhand started production in April 2009. The Company launched two brands, Divatrone and ProRetro in the market segment, Dydrogesterone, which was earlier dominated by a global pharma Company in August, 2021.On June 27, 2022, Infinity Holdings, an Indiafocused investment group acquired control over the Company consequent to acquisition of 43.73% of equity capital and became Promoters of the Company. The Company identified several products as part of new launches such as Indocap Gel, Lycored Plus, MemUp, Queezy ER to enhance healthcare professionals confidence and improve patient outcomes in 202324. It acquired the India and Bhutan business of Yash Pharma in May, 2024.
Read More

Jagsonpal Pharmaceuticals Ltd FAQs

Jagsonpal Pharmaceuticals Ltd share price is ₹228.5 in NSE and ₹229.25 in BSE as on 12/2/2025 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

Jagsonpal Pharmaceuticals Ltd share price in the past 1-year return was -24.41. The Jagsonpal Pharmaceuticals Ltd share hit a 1-year low of Rs. 109.44 and a 1-year high of Rs. 328.04.

The market cap of Jagsonpal Pharmaceuticals Ltd is Rs. 1516.44 Cr. as of 12/2/2025 12:00:00 AM.

The PE ratios of Jagsonpal Pharmaceuticals Ltd is 41.76 as of 12/2/2025 12:00:00 AM.

The PB ratios of Jagsonpal Pharmaceuticals Ltd is 7.71 as of 12/2/2025 12:00:00 AM

You can easily buy Jagsonpal Pharmaceuticals Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -